Effects of Probiotic Extracts of Kimchi on Immune Function in NC/Nga Mice

김치 추출 프로바이오틱스 섭취가 아토피 동물모델 NC/Nga mice에서 면역 지표에 미치는 영향

  • Lee, In-Hoe (Department of Medical Nutrition, Graduate School of East-West Medical Science, Research Institute of Clinical Nutrition, Kyung Hee University) ;
  • Lee, Sun-Hee (Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Lee, In-Seok (Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Park, Yoo-Kyoung (Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Chung, Dae-Kyun (Graduate School of Biotechnology and RNA Inc.) ;
  • Choue, Ryo-Won (Department of Medical Nutrition, Graduate School of East-West Medical Science, Research Institute of Clinical Nutrition, Kyung Hee University)
  • 이인회 (경희대학교 동서의학대학원 의학영양학과, 임상영양연구소) ;
  • 이순희 (경희대학교 동서의학대학원 의학영양학과) ;
  • 이인석 (경희대학교 동서의학대학원 의학영양학과) ;
  • 박유경 (경희대학교 동서의학대학원 의학영양학과) ;
  • 정대균 (생명공학원 및 (주)RNA) ;
  • 조여원 (경희대학교 동서의학대학원 의학영양학과, 임상영양연구소)
  • Published : 2008.02.28

Abstract

Atopic dermatitis (AD) is characterized by chronic relapsing inflammation and is associated with hyper-production of immunoglobulin E (IgE). Recent studies have suggested that one of the treatments to alleviate symptoms of AD could be a supplementation of probiotics, Lactobacillus, Rhamnosus, Bifidus, etc. The purpose of this study was to evaluate the effects of probiotics on immune parameters in NC/Nga mice treated with 1-chloro-2,4-dinitro-benzene (DNCB). To induce atopic dermatitis, DNCB was treated to the back of mice for 2 weeks. Then, NC/Nga mice were divided into the four experimental groups randomly. Probiotics fragment, probiotics with other complex (Lactobacillus rhamnosus GG, Bifidobacterium lactis Bb-12LbL, L. plantarum K8, L. plantarum K8 fragment, ${\gamma}$-linolenic acid), antihistamine, and distilled water were administrated orally to the NC/Nga mouse for 4 weeks of experimental period. The groups were probiotics fragment group (DPF), probiotics with other complex group (DPOC), antihistamine group (DAH) and distilled water group (DDW) as a control group. The levels of serum IgE, interlukin-4 (IL-4), interlukin-5 (IL-5), interferon-gamma (IFN-${\gamma}$) and spleenocyte IgE were measured. The levels of serum IgE were significantly different among the four experimental groups. Before the treatment, there was no differences among the groups. However, from the first through the third week of the treatments, the levels of serum IgE in the probiotics (DPF, DPOC) and antihistamine (DAH) groups were lower than those of control group (p < 0.05). The levels of serum IL-4 of DPOC group was significantly lower than that of control group (p < 0.05) and serum IL-5 levels of DPF, DPOC, and DAH groups were significantly lower than that of control group. The levels of serum IFN-${\gamma}$ were not different among the four experimental groups. The levels of serum IgE in supernatant of spleen lymphocytes were not significantly different among the groups. These results suggest that probiotics supplementation showed partial effectiveness in the DNCB treated NC/Nga mice via modulation of IgE level and IL-4, IL-5 production. Based on these findings, probiotics exhibited the inhibitory effect via IL-4 production thereby inhibited the production of IgE in atopic animal model NC/Nga mice.

아토피 피부염에서 유산균의 유익성에 대해서는 이미 많이 알려져 있고 우리나라 전통식품인 김치유산균의 유익성에 대한 연구도 많이 진행되었으나 아토피 피부염에서 김치 유산균의 효과에 관한 연구는 아직 미비한 실정이다. 본 연구에서는 아토피 동물 모델인 NC/Nga mice에 김치유산균에서 추출한 유산균(L.plantarum K8)의 파쇄물과 유산균 및 ${\gamma}$-리놀렌산 복합체(L.rhamnosus GG 생균, B. lactis Bb-12Lb 생균, L. plantarum K8생균, L. plantarum K8 파쇄물, ${\gamma}$-리놀렌산)를 경구 투여한 후 혈청 면역지표(IgE, IL-4, IL-5, IFN-${\gamma}$)와 비장 배양액에서 IgE 농도를 측정하였다. 실험동물의 체중 및 사료섭취량은 사육기간이 지남에 따라 증가하는 경향을 보였으며 각 군 간에 유의적인 차이는 관찰되지 않았다. 실험 시작 시 혈청 IgE 농도는 각 군 간에 차이가 나타나지 않았으나 실험 전 기간 4주 동안 유산균 파쇄물(DPF), 유산균 및 ${\gamma}$-리놀렌산 복합체(DPOC), 항히스타민(DAH)을 섭취한 군에서 증류수(DDW)만을 섭취군에 비하여 유의적으로 낮게 나타났다. 혈청 IFN-${\gamma}$ 농도는 각 군에서 유의적인 차이가 나타나지 않았으나 혈청 IL-4 농도는 유산균 및 ${\gamma}$-리놀렌산 복합체를 섭취한 군(DPOC)에서 대조군에 비하여 유의적으로 낮게 나타났다. 혈청 IL-5 농도는 유산균 파쇄물(DPF), 유산균 및 ${\gamma}$-리놀렌산 복합체(DPOC), 항히스타민(DAH)을 섭취한 군에서 모두 대조군에 비하여 유의적으로 낮았다. 비장 임파구 배양 상층액의 IgE 농도는 각 군에서 군 간 유의적인 차이가 나타나지 않았다. 결론적으로, 아토피 동물모델 NC/Nga mice에 유산균 파쇄물(DPF)과 유산균 및 감마리놀렌산 복합체(DPOC)의 경구투여는 혈청 IgE, IL-4, IL-5를 감소시키는 것으로 나타났으며, 김치로부터 추출한 프로바이오틱스를 아토피 환자에게 섭취시켰을 때 IgE, IL-4, IL-5 감소와 같은 긍정적인 효과를 볼 수 있을 것으로 기대한다. 여러 종류의 프로바이오틱스는 아토피의 증상완화 또는 면역 체계에 미치는 영향과 정확한 메카니즘을 밝히기 위하여 과학적인 연구가 필요한 것으로 사료된다.

Keywords

References

  1. The Census of Death Statistics. Korea National Statistical Office Seoul, Korea (2000)
  2. Hoolihan KL. Prophylactic and therapeutic uses of probiotics: A review. J. Am. Diet. Assoc. 101: 229-238 (2001) https://doi.org/10.1016/S0002-8223(01)00060-8
  3. Furrie E. Probiotics and allergy. P. Nutr. Soc. 64: 465-469 (2005) https://doi.org/10.1079/PNS2005466
  4. Park HS, Lee HS, Uhm TB. Selection of microorganisms for probiotics and their characterization. J. Korean Soc. Food Sci. Nutr. 27: 433-440 (1998)
  5. Gibson GR, Roberfroid MB. Dietary modulation of human colonic microbiota: Introducing the concept of probiotics. J. Nutr. 125: 1401-1412 (1995)
  6. Iolauri E, Arvola T, Sutas Y, Molilanen E, Salminene S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30: 1604-1610 (2000)
  7. Klliomaki M, Ouwehand A, Arvilommi H, Kero P, Isolauri E. Transforming growth factor beta in the breastmilk: A potential regulator of atopic disease at an early age. J. Allergy Clin. Immun. 104: 1251-1257 (1999) https://doi.org/10.1016/S0091-6749(99)70021-7
  8. Laiho K, Hoppu U, Ouwehand AC, Salminen S, Isolauri E. Probiotics: on-going research On atopic individuals. Br. J. Nutr. 88(Suppl): S19-S27 (2002) https://doi.org/10.1079/BJN2002626
  9. Yoon SP, Kim BS, Ree JH, Lee SC, Kim YK. The environment and lifestyle of atopic dermatitis patients. Korean J. Dermatol. 37: 983-991 (1999)
  10. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Islauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immun. 107: 129-134 (2001) https://doi.org/10.1067/mai.2001.111237
  11. Leung DYM. Immunopathology of atopic dermatitis. Semin. Ummunopathol. 13: 437-440 (1992)
  12. Hanifin JM. Atotic dermatitis. J. Am. Acad. Dermatol. 6: 1-13 (1982) https://doi.org/10.1016/S0190-9622(82)70001-5
  13. Pessi T, Sutas Y, Hurme M, Iolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy 30: 1804-1808 (2000) https://doi.org/10.1046/j.1365-2222.2000.00948.x
  14. Majamaa H, Isolauri E. Probiotics: A novel approach in management of food allergy. J. Allergy Clin. Immun. 99: 175-185 (1996)
  15. Ohmne JD, Hanifin JM, Nickoloff BJ. Over-expression of IL-10 in atopic dermatitis. J. Immunol. 154: 1956-1963 (1995)
  16. Yoshizawa Y, Nomaguchi H, Izaki S, Kitamura K. Serum cytokine levels in atopic dermatitis. Clin. Exp. Dermatol. 27: 225-229 (2002) https://doi.org/10.1046/j.1365-2230.2002.00987.x
  17. Horiuchi Y, Bae SJ, Katayama I, Nishioka K. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: Possible shift from a Th2- to Th1-predominance. J. Dermatol. Sci. 35: 187-197 (2004) https://doi.org/10.1016/j.jdermsci.2004.06.006
  18. Yoshiko H, Shuhji S, Eiji T, Takashi O, Yuji K, Katsunori A, Takashi M, Hoshio H. The mechanism of a defective IFN-gamma response to bacterial toxins in an atopic dermatitis model, NC/ Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis. J. Immunol. 166: 5439-5447 (2001) https://doi.org/10.4049/jimmunol.166.9.5439
  19. Matusaki T, Yamazaki R, Hashimoto S, Yokokura T. The effect of oral feeding of Lactobacillus casei strain shirota on immunoglobulin E production in mice. J. Dairy Sci. 81: 48-53 (1998) https://doi.org/10.3168/jds.S0022-0302(98)75549-3
  20. Choi SY, Lee HW, Chung KS. Effect of addition of nisin and Leuconostoc mesenteroids IFO 12060 on Escherichia coli growth in stored kimchi. J. Korean Soc. Food Nutr. 21: 414-417 (1992)
  21. Choi YO, Ahn C. Plasmid-associated bacteriocin production by Leuconostoc sp. LAB145 -3A isolated from Kimchi. J. Microbiol. Biotechnol. 7: 409-416 (1997)
  22. Ryu SH, Jeon YS, Moon JW, Lee YS, Moon GS. Effect of kimchi ingredients to reactive oxygen species in skin cell cytotoxicity. J. Korean Soc. Food Sci. Nutr. 26: 998-1005 (1997)
  23. Ryu SH, Jeon YS, Kwon MJ, Moon JW, Lee YS, Moon GS. Effect of kimchi extracts to reactive oxygen species in skin cell cytotoxicity. J. Korean Soc. Food Sci. Nutr. 26: 814-821 (1997)
  24. Kondo K, Nagami T, Teramoto S. Differences in hematopoietic death among inbredstrains of mice. pp. 20-29. In: Comparative Cellular and Species Radiosensitivity. Bond P, Sugahara T. (eds). Williams & Wilkins, Baltimore, MD, USA (1964)
  25. Mills LB, Mordan LJ, Roth HL, Winger EE, Epstein WL. Treatment of severe atopic dermatitis by topical immune modulation using dinitrochlorobenzene. J. Am. Acad. Dermatol. 42: 687-689 (2000) https://doi.org/10.1016/S0190-9622(00)90190-7
  26. Chae OW, Shin KS, Chung HK, Choe TB. Immunostimulation effects of mice fed with cell lysate of Lactobacillus plantarum isolated from Kimchi. Korean J. Biotechnol. Bioeng. 13: 424-430 (1998)
  27. Horrobin DF. Essential fatty acid metabolism and its modification in atopic eczema. Am. J. Clin. Nutr. 71: 367S-372S (2000) https://doi.org/10.1093/ajcn/71.1.367s
  28. Galland L. Increased requirements for essential fatty acids in atopic individuals: A review with clinical descriptions. J. Am. Coll. Nutr. 5: 213-228 (1986) https://doi.org/10.1080/07315724.1986.10720126
  29. Yoon S, Lee J, Lee S. The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma-interferon levels. Skin Pharmacol. Appl. 15: 20-25 (2002) https://doi.org/10.1159/000049385
  30. Engvall E, Perlman P. Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G. Immunochemistry 8: 871-874 (1971) https://doi.org/10.1016/0019-2791(71)90454-X
  31. Lim BO, Yamada K, Yoshimura K, Watanabe T, Pham H, Taniguchi S, Sugano M. Free bile acids inhibit IgE production by mouse spleen lymphocytes stimulated by lipopolysaccharide and interlukins. Biosci. Biotech. Biochem. 59: 624-627 (1995) https://doi.org/10.1271/bbb.59.624
  32. Lim BO, Choue RW, Park DK, Kim HC, Kim SY, Yamada K, Sugano M. Effect of dietary level of pectin on immunoglobulin and cytokine production by mesenteric lymph node and interlukin- 2 receptor in rat. Food Sci. Technol. Res. 8: 14-16 (2002) https://doi.org/10.3136/fstr.8.14
  33. Grewe M, Bruijnzeel-Koomen CA, Schpf E, Thepen T, Langeveld- Wildschut AG, Ruzicka T, Krutmann J. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 19: 359-361 (1998) https://doi.org/10.1016/S0167-5699(98)01285-7
  34. Uehara M, Kimura C. Descendant family history of atopic dermatitis. Acta Derm.-Venereol. 73: 62-63 (1993)
  35. Horan RF, Schneider LC, Sheffer AL. Allergic skin disorders and mastocytosis. J. Am. Med. Assoc. 268: 2858-2868 (1992) https://doi.org/10.1001/jama.268.20.2858
  36. Reinhold U, Wehrmann W, Kukel S, Kreysel HW. Evidence that defective interferon ${\gamma}$ production in atopic dermatitis patients is due to intrinsic abnormalities. Clin. Exp. Immun. 79: 74-79 (1990)
  37. Jujo K, Renz H, Abe J, Gelfand EW, Leung DY. Decreased interferon ${\gamma}$ and increased interlukin-4 production in atopic dermatitis promotes Ig E synthesis. J. Allergy Clin. Immun. 90: 323- 331 (1992) https://doi.org/10.1016/S0091-6749(05)80010-7
  38. Robinson DS, Hamid Q, Ying S, Sicopoulos AT, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant TH2- like bronchoalveolar T-lymphocyte population in atopic asthma. New Engl. J. Med. 326: 298-304 (1992) https://doi.org/10.1056/NEJM199201303260504
  39. Trapp CL, Chang CC, Halpern GM, Keen CL, Gershwin ME. The influence of chronic yogurt consumption on populations of young and elderly adults. Int. J. Immunother. 9: 53-64 (1993)
  40. Halpern GM, Vruwink KG, Van De Water J, Keen CL, Gershwin ME. Influence of long-term yoghurt consumption in young adults. Int. J. Immunother. 7: 205-210 (1991)
  41. Van de Water J, Keen CL, Gershwin ME. The influence of chronic yogurt consumption on immunity. J. Nutr. 129: S1492- S1495 (1999) https://doi.org/10.1093/jn/129.7.1492S
  42. Vaarala O. Immunological effects of probiotics with special reference to lactobacilli. Clin. Exp. Allergy 33: 1634-1640 (2003) https://doi.org/10.1111/j.1365-2222.2003.01835.x
  43. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J. Clin. Invest. 108: 1865- 1873 (1991)
  44. White MV, Slater JE, Kaliner MA. Histamine and asthma. Am. Rev. Respir. Dis. 153: 1665-1676 (1987)
  45. Antoine OM, Laurent GM, Christophe AC, Monique MB, Felix AM, Chantal MG, Brice BC, Sabine JP, Vincent F, Pierre B, Daniel V. Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma, Am. J. Respir. Crit. Care 161: 1790-1796 (2002)
  46. Cross ML. Microbes vs. microbes: Immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol. Med. Mic. 34: 245-253 (2002) https://doi.org/10.1111/j.1574-695X.2002.tb00632.x
  47. Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, Savilahti E. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J. Allergy Clin. Immun. 114: 131-136 (2004) https://doi.org/10.1016/j.jaci.2004.03.036
  48. Renz H, Jujo K, Bradley J, Dementico J, Gelfand EW, Leung DV. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-${\gamma}$. J. Invest. Dermatol. 99: 403-408 (1992) https://doi.org/10.1111/1523-1747.ep12616114
  49. Pochard P, Gosset P, Grangette C. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J. Allergy Clin. Immun. 110: 617-623 (2002) https://doi.org/10.1067/mai.2002.128528
  50. Ricci M. IL-4: A key cytokine in atopy. Clin. Exp. Allergy 24: 801 (1994) https://doi.org/10.1111/j.1365-2222.1994.tb01803.x